12/04/2025
I can’t believe there are still countries that do not permit slings for stress urinary incontinence. This post is my response to a post by a compassionate patient-centric urogynecologist friend in Ireland,frustrated by how their country still bans all mesh preventing him from inserting slings in women with incontinence. A link to his post on LinkedIn sits at the bottom of this article.
***
APOPS continues to receive comments from women daily, terrified to move forward with incontinence or POP surgery due to past missteps that have been addressed in the majority of the countries of the world. The fear generated by inaccurate and dated mesh mess rhetoric is so unsettling.
It saddens me when I hear from women who want mesh and have no access to the tool. I applaud Barry O'Reilly's efforts to provide procedures that should be patient choice. Clearly if mesh was the enemy, the majority of countries would have blocked usage back in 2011 in the US or 2019 which reverberated globally when issues arose. Qualified, highly skilled subspecialists providing these procedures is a critical component of success.
I spoke at the FDA in both 2011 and 2019 related to the POP/UI mesh issues, had spoken to hundreds of women who had complications in the early days, and tens of thousands who have had mesh success since. The research related to both complication causes and what we could do to improve valuable tools to address the pandemic prevalence of urinary incontinence and pelvic organ prolapse has clarified so much. Changes were made post 2011, and again at the 2019 point.
We have now moved on to sacrocolpopexy as the gold standard for POP and slings are considered the gold standard repair for UI globally, minus zones that drag their heels clinging to outdated data.
It bears repeating; patient voice is a pivotal piece of the conversation. No woman is forced to have a mesh procedure. Women deserve the mesh option once the surgeon discloses the risks/benefits which will vary woman to woman due to lifestyle, behavioral, and comorbid condition intersects.
It is clear that mesh placement is a field of practice that requires guidelines. Appropriate incision size, proper mesh insertion location, preparation of mesh insertion site, possible topical estrogen use pre and/or post-surgery, degree of mesh tension, a two-layer closure, and low mesh density/increased porosity, mesh flexibility are important considerations for a quality mesh procedure. Subspecialists only should be providing these procedures.
Here is Professor/urogynecologist Barry O’Reilly’s post from LinkedIn:
https://lnkd.in/gtieCR_S
The Irish Independent has today highlighted an issue that deeply affects many women: the lack of access to specific, evidence-based surgical treatments for stress urinary incontinence in Ireland. My decision to collaborate with an international centre to provide this procedure comes from a single pr...